{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:48:02Z","timestamp":1784641682187,"version":"3.55.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ando.2024.01.005","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T16:09:05Z","timestamp":1705766945000},"page":"284-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) for the diagnosis of Cushing's syndrome: Genetics of Cushing's syndrome"],"prefix":"10.1016","volume":"85","author":[{"given":"Laetitia","family":"Martinerie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Bouligand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Odile","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Bertherat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Assi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9584-4294","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Espiard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2024.01.005_bib0720","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ando.2022.02.001","article-title":"Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome","volume":"83","author":"Tabarin","year":"2022","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2024.01.005_bib0760","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2019-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes","volume":"94","author":"Bertherat","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib0765","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa002","article-title":"Frequency and incidence of carney complex manifestations: a prospective multicenter study with a three-year follow-up","volume":"105","author":"Espiard","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib0795","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/humu.21178","article-title":"Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update","volume":"31","author":"Horvath","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ando.2024.01.005_bib0805","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/1078-0432.CCR-07-1155","article-title":"Large deletions of the PRKAR1A gene in Carney complex","volume":"14","author":"Horvath","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ando.2024.01.005_bib1155","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1310","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1530\/EJE-13-0740","article-title":"Systematic screening for PRKAR1A gene rearrangement in Carney complex: identification and functional characterization of a new in-frame deletion","volume":"170","author":"Bataille","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib0865","doi-asserted-by":"crossref","first-page":"E1501","DOI":"10.1210\/jc.2013-4237","article-title":"ARMC5 mutations are a frequent cause of primary macronodular adrenal hyperplasia","volume":"99","author":"Alencar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1315","doi-asserted-by":"crossref","first-page":"E1784","DOI":"10.1210\/jc.2014-1265","article-title":"ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1320","doi-asserted-by":"crossref","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","article-title":"Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation","volume":"99","author":"Faucz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1325","doi-asserted-by":"crossref","first-page":"E926","DOI":"10.1210\/jc.2014-4204","article-title":"ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences","volume":"100","author":"Espiard","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1330","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2014-2648","article-title":"Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma","volume":"100","author":"Elbelt","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1335","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-15-0642","article-title":"ARMC5 mutations in a large French-Canadian family with cortisol-secreting \u03b2-adrenergic\/vasopressin responsive bilateral macronodular adrenal hyperplasia","volume":"174","author":"Bourdeau","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib1340","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2024.01.005_bib0835","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(21)00236-9","article-title":"Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study","volume":"9","author":"Chasseloup","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib0840","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.gim.2021.09.018","article-title":"KDM1A inactivation causes hereditary food-dependent Cushing syndrome","volume":"24","author":"Vaczlavik","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.ando.2024.01.005_bib0965","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1530\/EC-18-0526","article-title":"Adrenocortical carcinoma in patients with MEN1: a kindred report and review of the literature","volume":"8","author":"Wang","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2024.01.005_bib0970","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-002-6492-4","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1","volume":"26","author":"Langer","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2024.01.005_bib0980","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d\u2019etude des tumeurs endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib1065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4158\/EP.14.5.595","article-title":"Diagnosis by serendipity: Cushing syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 gene mutation","volume":"14","author":"Alzahrani","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2024.01.005_bib1145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2265.2011.04220.x","article-title":"Cushing's syndrome in multiple endocrine neoplasia type 1","volume":"76","author":"Simonds","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2024.01.005_bib1345","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1507\/endocrj.K10E-218","article-title":"A case of ACTH-independent macronodular adrenal hyperplasia associated with multiple endocrine neoplasia type 1","volume":"58","author":"Yoshida","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2024.01.005_bib1350","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00423-006-0124-7","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1: results of 7\u00a0years prospective screening","volume":"392","author":"Waldmann","year":"2007","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.ando.2024.01.005_bib1000","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/jc.2009-0516","article-title":"Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors","volume":"94","author":"Hsiao","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1355","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: a clinical and molecular genetic investigation","volume":"90","author":"Matyakhina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1360","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","article-title":"Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer","volume":"189","author":"Shuch","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.ando.2024.01.005_bib1365","article-title":"Cardiac myxoma caused by fumarate hydratase gene deletion in patient with cortisol-secreting adrenocortical adenoma","volume":"105:dgaa163.","author":"Suda","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1015","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jjco\/hyp093","article-title":"Biallelic APC inactivation was responsible for functional adrenocortical adenoma in familial adenomatous polyposis with novel germline mutation of the APC gene: report of a case","volume":"39","author":"Hosogi","year":"2009","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ando.2024.01.005_bib1370","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3109\/07435800009048600","article-title":"Cortisol producing adrenal adenoma--a new manifestation of Gardner's syndrome","volume":"26","author":"Beuschlein","year":"2000","journal-title":"Endocr Res"},{"key":"10.1016\/j.ando.2024.01.005_bib1375","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2169\/internalmedicine.36.536","article-title":"Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas\/carcinomas which showed a point mutation in the APC gene","volume":"36","author":"Yamakita","year":"1997","journal-title":"Intern Med"},{"issue":"21","key":"10.1016\/j.ando.2024.01.005_bib1380","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","article-title":"Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers","volume":"16","author":"Gaujoux","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ando.2024.01.005_bib1385","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/EJE-14-1154","article-title":"amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations","volume":"172","author":"Lodish","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib1390","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.humpath.2014.09.005","article-title":"amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes","volume":"46","author":"Carney","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ando.2024.01.005_bib1030","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/PAS.0b013e31821ec4ce","article-title":"Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome","volume":"35","author":"Carney","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2024.01.005_bib1395","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1210\/jc.2002-021362","article-title":"Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene","volume":"88","author":"Fragoso","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1400","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000501169","article-title":"A novel GNAS mutation causing isolated infantile Cushing's syndrome","volume":"92","author":"Dejkhamron","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ando.2024.01.005_bib1405","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-3476(99)70302-1","article-title":"Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome","volume":"134","author":"Kirk","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.ando.2024.01.005_bib1410","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/eje.1.02004","article-title":"Molecular genetics of adrenocortical tumours, from familial to sporadic diseases","volume":"153","author":"Lib\u00e9","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib1415","first-page":"1444","article-title":"Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors","volume":"78","author":"Gicquel","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1420","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jmg.2008.058958","article-title":"High frequency of de novo mutations in Li-Fraumeni syndrome","volume":"46","author":"Gonzalez","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.ando.2024.01.005_bib0725","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1210\/jc.2010-1885","article-title":"Wnt\/\u03b2-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors","volume":"96","author":"Bonnet","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib0730","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1055\/s-0034-1389993","article-title":"From \u03b2-catenin to ARM-repeat proteins in adrenocortical disorders","volume":"46","author":"Berthon","year":"2014","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ando.2024.01.005_bib0735","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1055\/s-0034-1385908","article-title":"Protein kinase A alterations in adrenocortical tumors","volume":"46","author":"Espiard","year":"2014","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ando.2024.01.005_bib0740","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3390\/biomedicines9101397","article-title":"Bilateral adrenal hyperplasia: pathogenesis and treatment","volume":"9","author":"Chevalier","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ando.2024.01.005_bib0745","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1310067","article-title":"ACTH-independent massive bilateral adrenal disease (AIMBAD): a subtype of Cushing's syndrome with major diagnostic and therapeutic implications","volume":"131","author":"Lieberman","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib0750","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib0755","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2019-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes","volume":"94","author":"Bertherat","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib0770","first-page":"180","article-title":"Genetics of adrenocortical tumors: Carney complex","volume":"62","author":"Stratakis","year":"2001","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2024.01.005_bib0775","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1172\/JCI10841","article-title":"Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex","volume":"106","author":"Casey","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2024.01.005_bib0780","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.ando.2024.01.005_bib0785","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI118467","article-title":"Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2","volume":"97","author":"Stratakis","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2024.01.005_bib0790","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jmg.40.4.268","article-title":"Chromosome 2 (2p16) abnormalities in Carney complex tumours","volume":"40","author":"Matyakhina","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.ando.2024.01.005_bib0800","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2005-2708","article-title":"A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds","volume":"91","author":"Groussin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib0810","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng1809","article-title":"A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia","volume":"38","author":"Horvath","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.ando.2024.01.005_bib0815","doi-asserted-by":"crossref","first-page":"E208","DOI":"10.1210\/jc.2010-1704","article-title":"Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype","volume":"96","author":"Lib\u00e9","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib0820","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2265.2012.04366.x","article-title":"Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours","volume":"77","author":"Rothenbuhler","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2024.01.005_bib0825","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ejhg.2008.85","article-title":"A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex","volume":"16","author":"Horvath","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ando.2024.01.005_bib0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03689.x","article-title":"Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction","volume":"73","author":"Lacroix","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2024.01.005_bib0845","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assie","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2024.01.005_bib0850","doi-asserted-by":"crossref","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","article-title":"Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation","volume":"99","author":"Faucz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib0855","doi-asserted-by":"crossref","first-page":"E926","DOI":"10.1210\/jc.2014-4204","article-title":"ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences","volume":"100","author":"Espiard","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib0860","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/EJE-21-1032","article-title":"Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients","volume":"187","author":"Bouys","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib0870","doi-asserted-by":"crossref","first-page":"E1784","DOI":"10.1210\/jc.2014-1265","article-title":"ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib0875","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2014-2648","article-title":"Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma","volume":"100","author":"Elbelt","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib0880","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-20-0014","article-title":"Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report","volume":"183","author":"Jojima","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib0885","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.4158\/EP15756.OR","article-title":"Germline deletion of Armc5 in familial primary macronodular adrenal hyperplasia","volume":"21","author":"Suzuki","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2024.01.005_bib0890","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/ERC-19-0502","article-title":"Cullin 3 targets the tumor suppressor gene ARMC5 for ubiquitination and degradation","volume":"27","author":"Cavalcante","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2024.01.005_bib0895","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM199210013271403","article-title":"Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide","volume":"327","author":"Reznik","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2024.01.005_bib0900","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199210013271402","article-title":"Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome","volume":"327","author":"Lacroix","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2024.01.005_bib0905","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/EJE-10-0195","article-title":"Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome","volume":"163","author":"Lib\u00e9","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib0910","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92184","article-title":"Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome","volume":"2","author":"Lecoq","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ando.2024.01.005_bib0915","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1158\/0008-5472.CAN-17-1900","article-title":"Germline lysine-specific demethylase 1 (LSD1\/KDM1A) mutations confer susceptibility to multiple myeloma","volume":"78","author":"Wei","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.ando.2024.01.005_bib0920","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2024.01.005_bib0925","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.humpath.2014.09.005","article-title":"Germline PRKACA amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes","volume":"46","author":"Carney","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ando.2024.01.005_bib0930","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1210\/me.2002-0099","article-title":"Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity","volume":"16","author":"Swords","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib0935","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2003.10.052","article-title":"Constitutive activation of the human ACTH receptor resulting from a synergistic interaction between two naturally occurring missense mutations in the MC2R gene","volume":"213","author":"Swords","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib0940","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","article-title":"Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors","volume":"14","author":"Libe","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ando.2024.01.005_bib0945","doi-asserted-by":"crossref","first-page":"E2063","DOI":"10.1210\/jc.2012-2275","article-title":"Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors","volume":"97","author":"Vezzosi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib0950","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345666","article-title":"Multiple endocrine neoplasia type 1","volume":"41","author":"Agarwal","year":"2013","journal-title":"Front Horm Res"},{"key":"10.1016\/j.ando.2024.01.005_bib0955","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00423-006-0124-7","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1: results of 7\u00a0years prospective screening","volume":"392","author":"Waldmann","year":"2007","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.ando.2024.01.005_bib0960","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d\u2019etude des Tumeurs endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib0975","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1507\/endocrj.K10E-218","article-title":"A case of ACTH-independent macronodular adrenal hyperplasia associated with multiple endocrine neoplasia type 1","volume":"58","author":"Yoshida","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2024.01.005_bib0985","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1677\/ERC-09-0082","article-title":"Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia","volume":"16","author":"Harding","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2024.01.005_bib0990","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","article-title":"Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer","volume":"189","author":"Shuch","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.ando.2024.01.005_bib0995","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation","volume":"90","author":"Matyakhina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-4-22","article-title":"Familial adenomatous polyposis","volume":"4","author":"Half","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ando.2024.01.005_bib1010","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","article-title":"Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers","volume":"16","author":"Gaujoux","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ando.2024.01.005_bib1020","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory G protein in the McCune-Albright syndrome","volume":"325","author":"Weinstein","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2024.01.005_bib1025","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1073\/pnas.89.11.5152","article-title":"Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome","volume":"89","author":"Schwindinger","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2024.01.005_bib1035","doi-asserted-by":"crossref","first-page":"E687","DOI":"10.1210\/jc.2011-3000","article-title":"Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations","volume":"97","author":"Almeida","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1040","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1210\/jc.2002-021362","article-title":"Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene","volume":"88","author":"Fragoso","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/eje.1.02004","article-title":"Molecular genetics of adrenocortical tumours, from familial to sporadic diseases","volume":"153","author":"Libe","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib1050","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1126\/science.1249480","article-title":"Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome","volume":"344","author":"Cao","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ando.2024.01.005_bib1055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng.2956","article-title":"Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors","volume":"46","author":"Goh","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.ando.2024.01.005_bib1060","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1126\/science.1252328","article-title":"Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome","volume":"344","author":"Sato","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ando.2024.01.005_bib1070","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3109\/07435800009048600","article-title":"Cortisol producing adrenal adenoma--a new manifestation of Gardner's syndrome","volume":"26","author":"Beuschlein","year":"2000","journal-title":"Endocr Res"},{"key":"10.1016\/j.ando.2024.01.005_bib1075","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.ando.2024.01.005_bib1080","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamaoncol.2019.1558","article-title":"Value of molecular classification for prognostic assessment of adrenocortical carcinoma","volume":"5","author":"Assi\u00e9","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ando.2024.01.005_bib1085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jmg.2008.057570","article-title":"Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families","volume":"45","author":"Bougeard","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.ando.2024.01.005_bib1090","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ando.2024.01.005_bib1095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mce.2011.09.040","article-title":"Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults","volume":"351","author":"Faria","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib1100","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1200\/JCO.2012.46.3711","article-title":"Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors","volume":"31","author":"Cust\u00f3dio","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ando.2024.01.005_bib1105","doi-asserted-by":"crossref","first-page":"E476","DOI":"10.1210\/jc.2011-1982","article-title":"TP53 germline mutations in adult patients with adrenocortical carcinoma","volume":"97","author":"Herrmann","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1110","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2012-2198","article-title":"Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma","volume":"98","author":"Raymond","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2011.09.010","article-title":"Towards an understanding of the role of p53 in adrenocortical carcinogenesis","volume":"351","author":"Wasserman","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib1120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2011-2244","article-title":"A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer","volume":"97","author":"Anselmo","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1125","doi-asserted-by":"crossref","first-page":"E202","DOI":"10.1210\/jc.2011-2321","article-title":"Carney complex with adrenal cortical carcinoma","volume":"97","author":"Morin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1210\/jc.2011-3327","article-title":"Adrenocortical cancer in Carney complex: a paradigm of endocrine tumor progression or an association of genetic predisposing factors?","volume":"97","author":"Bertherat","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1135","first-page":"5308","article-title":"Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity","volume":"63","author":"Bertherat","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ando.2024.01.005_bib1140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ccell.2016.07.013","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"30","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ando.2024.01.005_bib1150","first-page":"76","article-title":"Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1","volume":"75","author":"Skogseid","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.ando.2024.01.005_bib1165","doi-asserted-by":"crossref","first-page":"E997","DOI":"10.1210\/jc.2015-1453","article-title":"The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing's disease","volume":"100","author":"Perez-Rivas","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1170","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1210\/jc.2017-00161","article-title":"Somatic USP8 gene mutations are a common cause of pediatric Cushing disease","volume":"102","author":"Faucz","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1175","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","article-title":"Recurrent gain-of-function USP8 mutations in Cushing's disease","volume":"25","author":"Ma","year":"2015","journal-title":"Cell Res"},{"key":"10.1016\/j.ando.2024.01.005_bib1180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-15-0689","article-title":"The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease","volume":"174","author":"Hayashi","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib1290","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1399-0004.2010.01406.x","article-title":"The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes","volume":"78","author":"Stratakis","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.ando.2024.01.005_bib1295","doi-asserted-by":"crossref","first-page":"E663","DOI":"10.1210\/jc.2011-2291","article-title":"mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients","volume":"97","author":"Cazabat","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1300","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s40618-017-0725-8","article-title":"Frequency of familial pituitary adenoma syndromes among patients with functioning pituitary adenomas in a reference outpatient clinic","volume":"40","author":"Marques","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2024.01.005_bib1305","first-page":"140105","article-title":"An unusual case of an ACTH-secreting macroadenoma with a germline variant in the aryl hydrocarbon receptor-interacting protein (AIP) gene","volume":"2015","author":"Dinesen","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.ando.2024.01.005_bib1195","first-page":"2642","article-title":"Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred","volume":"81","author":"Burgess","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1200","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/cen.14067","article-title":"Paediatric and young adult manifestations and outcomes of multiple endocrine neoplasia type 1","volume":"91","author":"Herath","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2024.01.005_bib1205","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 study group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1210","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verg\u00e8s","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1215","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/eje.0.1510709","article-title":"Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1","volume":"151","author":"Rix","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib1220","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/cen.13796","article-title":"Children with MEN1 gene mutations may present first (and at a young age) with Cushing disease","volume":"89","author":"Makri","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2024.01.005_bib1225","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2265.2004.01943.x","article-title":"Cushing's disease as the first clinical manifestation of multiple endocrine neoplasia type 1 (MEN1) associated with an R460X mutation of the MEN1 gene","volume":"60","author":"Matsuzaki","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2024.01.005_bib1230","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1235","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2019-00082","article-title":"Clinical features of multiple endocrine neoplasia type 4: novel pathogenic variant and review of published cases","volume":"104","author":"Frederiksen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1240","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1210\/clinem\/dgaa160","article-title":"Germline CDKN1B loss-of-function variants cause pediatric Cushing's disease with or without an MEN4 phenotype","volume":"105","author":"Chasseloup","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1190","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-17-0227","article-title":"PRKAR1A mutation causing pituitary-dependent Cushing disease in a patient with Carney complex","volume":"177","author":"Kiefer","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib1285","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/ERC-17-0131","article-title":"Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease","volume":"24","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2024.01.005_bib1245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","article-title":"Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations","volume":"128","author":"de Kock","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ando.2024.01.005_bib1250","doi-asserted-by":"crossref","first-page":"E1487","DOI":"10.1210\/jc.2014-1016","article-title":"Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing's disease","volume":"99","author":"Sahakitrungruang","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1425","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10689-016-9958-5","article-title":"Embryonal rhabdomyosarcoma in a patient with a heterozygous frameshift variant in the DICER1 gene and additional manifestations of the DICER1 syndrome","volume":"16","author":"Fremerey","year":"2017","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ando.2024.01.005_bib1430","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11102-011-0328-x","article-title":"Pituitary blastoma: a unique embryonal tumor","volume":"15","author":"Scheithauer","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2024.01.005_bib1275","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1210\/jc.2019-00697","article-title":"Germline USP8 mutation associated with pediatric Cushing disease and other clinical features: a new syndrome","volume":"104","author":"Cohen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.005_bib1255","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2265.2007.02941.x","article-title":"Cushing's syndrome due to a pituitary corticotropinoma in a child with tuberous sclerosis: an association or a coincidence?","volume":"67","author":"Nandagopal","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2024.01.005_bib1260","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2265.2005.02374.x","article-title":"Simultaneous Cushing's disease and tuberous sclerosis; a potential role for TSC in pituitary ontogeny","volume":"63","author":"Tigas","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2024.01.005_bib1265","first-page":"1","article-title":"Cushing disease in a patient with multiple endocrine neoplasia type 2B","volume":"4","author":"Kasturi","year":"2017","journal-title":"J Clin Transl Endocrinol Case Rep"},{"key":"10.1016\/j.ando.2024.01.005_bib1270","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/cen.12072","article-title":"Confusing genes: a patient with MEN2A and Cushing's disease","volume":"78","author":"Naziat","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2024.01.005_bib1185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2010.04.027","article-title":"PRKAR1A and the evolution of pituitary tumors","volume":"326","author":"Kirschner","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2024.01.005_bib1280","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jc.2015-3324","article-title":"The CABLES1 Gene in glucocorticoid regulation of pituitary corticotrope growth and Cushing disease","volume":"101","author":"Roussel-Gervais","year":"2016","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426624000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426624000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T10:42:20Z","timestamp":1728470540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426624000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":143,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0003426624000052"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2024.01.005","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) for the diagnosis of Cushing's syndrome: Genetics of Cushing's syndrome","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2024.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}